Scientists believe that psilocybin could be used to treat a wide variety of psychological ailments, but if they want to run experiments, they need access to it
Rep. Earl Blumenauer (D-OR) is supporting Oregon initiative to legalize psilocybin mushrooms for therapeutic purposes & helping raise money for the campaign
Pharma veteran Doug Drysdale has joined psychedelics-focused life sciences company Cybin Corp.
Prometheus met New Yorkers throughout the city to trip on psychedelics with them, not just for fun—the trip buddies are his clients, and he is their guide
Compass Pathways, backed by PayPal (PYPL) and Palantir co-founder Peter Thiel, filed for a U.S. IPO to trade on the Nasdaq Global Market under the ticker CMPS.
Eleusis was founded in 2014 with the mission of turning psychedelics into anti-inflammatories
Dr. Price wants to build a group of open-minded psychedelic enthusiasts, cultivate mindfulness, and eventually meetup for physically distant hikes or events.
“Once science really catches up to just how effective that is for people who aren’t being served by the current medical system, we can become allies.”